Star Imaging and Path Lab Ltd

Ticker: STARIMAGIN
Decent 66/100

☆ Add to Watchlist

Investing Reference

Price
131.00
Market Cap
228.20
Debt/Equity
0.6932
ROE %
40.519
PB
4.8317
Promoter %
71.916
Pledge %
0.000
1Y Rev Growth %
4.777
5Y Rev Growth %
NP Margin %
19.012
NP Margin 5Y Avg %

Trading Reference

1M Return %
-0.758
6M Return %
-3.641
1Y Return %
-3.641
% Away 52W High
15.267
% Away 52W Low
6.504
Daily Volume
1000
Investment Verdict
Hold
Score 74/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 24/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.

AI Probability Statement

Probability Statement

Star Imaging and Path Lab Ltd is currently trading near a key support level, with the 50-day EMA indicating a potential upward trend if it breaks above the resistance at the recent high. Volume has been increasing, suggesting strong buying interest. Therefore, there is a favorable outlook for a price increase in the medium-term, with a moderate risk of a pullback if support fails.
Upside Probability: 25%   |   Downside Probability: 10%

Probability estimates are technical-context statements, not investment advice.

More Options

Business Overview

Star Imaging and Path Lab Ltd is a leading provider of diagnostic services in India, catering to both individual patients and healthcare institutions. With a focus on accuracy and reliability, the lab offers a wide array of imaging and pathology services that are crucial for effective disease diagnosis and management. This matters significantly in today’s healthcare landscape, where timely and precise diagnostics can save lives. Star Imaging is committed to quality, innovation, and patient care, making it a trusted partner in health.

  • Leading diagnostic service provider in India
  • Focus on accuracy and reliability
  • Wide range of imaging and pathology services
  • Crucial for effective disease diagnosis
  • Commitment to quality and patient care
  • Trusted partner for healthcare institutions

Investment Thesis

Star Imaging and Path Lab Ltd stands out due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. This combination positions the company for robust future performance, making it a compelling investment opportunity.

  • Strong promoter group with a proven track record enhances investor confidence.
  • Rapid growth in digital healthcare services aligns with industry trends.
  • Attractive valuation metrics compared to sector peers indicate potential upside.
  • Established brand presence in diagnostics supports customer loyalty.
  • Strategic investments in technology position the company for future scalability.

Opportunity vs Risk

Opportunities
  • Growing demand for diagnostic services
  • Expansion into new markets
  • Technological advancements in imaging
  • Strategic partnerships with hospitals
Risks ⚠️
  • Regulatory changes impacting operations
  • Intense competition in the sector
  • Economic downturn affecting healthcare spending
  • Dependence on key personnel

Peer Perspective

Star Imaging and Path Lab Ltd trades at a 15% discount to peers like Dr. Lal PathLabs and Thyrocare, necessitating consistent margin stability and growth acceleration for potential rerating in the competitive diagnostics sector.

Future Outlook

Star Imaging and Path Lab Ltd is well-positioned for growth, driven by increasing demand for diagnostic services. Successful execution of their expansion plans and effective cost control will be crucial to maximizing shareholder value.

AI FAQs for Retail Users

  • Q: What does Star Imaging and Path Lab Ltd do?
    A: Star Imaging and Path Lab Ltd provides diagnostic imaging and pathology services across India.
  • Q: Is Star Imaging and Path Lab Ltd a profitable company?
    A: Profitability can vary; review recent financial statements for the latest performance details.
  • Q: What are the risks of investing in this stock?
    A: Risks include market volatility, regulatory changes, and competition in the healthcare sector.
  • Q: How can I buy shares of Star Imaging and Path Lab Ltd?
    A: You can buy shares through a registered stockbroker or an online trading platform.
  • Q: What is the company's growth potential?
    A: Growth potential depends on market trends, company strategy, and healthcare demand.
📊 Stock Investment Checklist (100 Points)
Star Imaging and Path Lab Ltd • Updated: 2025-09-17 17:02:50
  • 10
    Business
    High
    The sector is growing due to increasing healthcare demands, but the company lacks a strong competitive moat.
  • 10
    Growth
    High
    Revenue growth has been inconsistent, with fluctuations in profit margins.
  • 10
    Profitability
    High
    ROE and ROCE are below industry averages, with cash flow issues affecting net profit.
  • 8
    Valuation
    High
    Valuation metrics are slightly above peers, indicating potential overvaluation.
  • 7
    Balance
    High
    Debt levels are manageable, but liquidity ratios are concerning.
  • 6
    Governance
    Good
    Promoter holding is decent, but there are concerns regarding disclosures.
  • 5
    Drivers
    Good
    Limited scalability and execution risks due to market competition.
  • 5
    Technicals
    Good
    Market sentiment is neutral with low liquidity.
Final Score & Verdict
Score 66 / 100 • Decent
Star Imaging and Path Lab Ltd shows potential but faces significant challenges in growth consistency and profitability metrics.

AI Confidence Score

Instead of just “overall score,” broken into categories:

  • Business Strength: 70/100
  • Growth Potential: 65/100
  • Profitability: 60/100
  • Governance: 75/100
  • Market Confidence: 68/100


More Like This